• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male.

作者信息

Koch M, Lang P, Bader P, Kreyenberg H, Schumm M, Scheel-Walter H, Hochhaus A, Niethammer D, Greil J

出版信息

Bone Marrow Transplant. 2003 Sep;32(5):541-2. doi: 10.1038/sj.bmt.1704167.

DOI:10.1038/sj.bmt.1704167
PMID:12942103
Abstract
摘要

相似文献

1
Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male.一名16岁男性在使用伊马替尼及含伊马替尼的预处理方案治疗淋巴细胞性原始细胞危象慢性粒细胞白血病后成功进行非亲缘异基因干细胞移植。
Bone Marrow Transplant. 2003 Sep;32(5):541-2. doi: 10.1038/sj.bmt.1704167.
2
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantation.甲磺酸伊马替尼(STI571)诱导一名慢性粒细胞白血病淋巴母细胞危象患者在异基因干细胞移植后复发达到稳定分子缓解。
Bone Marrow Transplant. 2003 Apr;31(7):611-4. doi: 10.1038/sj.bmt.1703885.
3
[Successful induction of complete cytogenetic response with high-dose imatinib mesylate and subsequent allogeneic stem cell transplantation for CML blastic crisis].[大剂量甲磺酸伊马替尼成功诱导完全细胞遗传学缓解并随后进行异基因干细胞移植治疗慢性粒细胞白血病急变期]
Rinsho Ketsueki. 2003 Jun;44(6):386-90.
4
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.使用600毫克伊马替尼治疗的急变期慢性髓性白血病:6年随访后存活患者的结局
Haematologica. 2008 Dec;93(12):1792-6. doi: 10.3324/haematol.13068. Epub 2008 Oct 6.
5
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
Am J Hematol. 2009 Oct;84(10):679-82. doi: 10.1002/ajh.21489.
6
Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.伊马替尼时代慢性粒细胞白血病的早期异基因干细胞移植:初步评估
Blood Cells Mol Dis. 2006 Sep-Oct;37(2):116-24; discussion 125-7. doi: 10.1016/j.bcmd.2006.06.006. Epub 2006 Aug 10.
7
Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).异基因造血细胞移植(异基因HCT)用于治疗小儿费城染色体阳性急性淋巴细胞白血病(ALL)。
Pediatr Blood Cancer. 2009 Dec 15;53(7):1289-94. doi: 10.1002/pbc.22263.
8
Recurrence of lymphoid blast crisis over 20 years after successful sibling allo-SCT for CML: short lived complete cytogenetic response to imatinib.
Bone Marrow Transplant. 2009 Aug;44(4):267-8. doi: 10.1038/bmt.2009.11. Epub 2009 Feb 23.
9
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.伊马替尼时代慢性髓性白血病的异基因造血细胞移植:一项回顾性多中心研究
Eur J Haematol. 2006 Jan;76(1):9-17. doi: 10.1111/j.0902-4441.2005.t01-1-EJH2321.x.
10
Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.在异基因造血细胞移植(allo-HCT)前或后使用伊马替尼不会增加慢性髓性白血病患者的心脏毒性。
Bone Marrow Transplant. 2009 Aug;44(3):169-74. doi: 10.1038/bmt.2008.441. Epub 2009 Feb 9.